These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A comparison of three immunosuppressive protocols in patients aged over 50 years. Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374 [No Abstract] [Full Text] [Related]
10. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone. Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454 [No Abstract] [Full Text] [Related]
11. Effect of DR and DR6 matching on cadaver kidney transplant survival. Reyman TA; Toledo-Pereyra LH Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848 [No Abstract] [Full Text] [Related]
12. Strategy for improving retransplantation in the CyA era. Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292 [No Abstract] [Full Text] [Related]
13. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping. Stuart FP; Stuart JK; Thistlethwaite JR; Gaber AO; Mayes J Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656 [No Abstract] [Full Text] [Related]
14. The results of renal transplantation with cyclosporine in immunologically high-risk patients. Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047 [No Abstract] [Full Text] [Related]
15. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol. Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564 [No Abstract] [Full Text] [Related]
16. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Gaber AO; Thistlethwaite JR; Haag BW; Stuart JK; Mayes JT; Lloyd DM; Fellner S; Stuart FP Am Surg; 1987 Jul; 53(7):407-9. PubMed ID: 3300451 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients. Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065 [No Abstract] [Full Text] [Related]
18. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone. MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557 [No Abstract] [Full Text] [Related]
19. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone. Schweizer RT; Rovelli M; Roper L; Bartus SA Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062 [No Abstract] [Full Text] [Related]